IMUPSORA OIL

Indications

• Anti-inflammatory conditions
• Osteoarthritis
• Rheumatoid arthritis
• Digestive disorders
• Skin conditions
• Metabolic syndrome

Dosage

Adults: There is no standard dosage for haldi as it depends on the form used (powder, capsules, etc.) and the intended purpose. General guidance suggests 400-600 mg of curcumin

Mechanism of action

Curcumin, the active ingredient in haldi, exerts its effects through multiple mechanisms, including the modulation of various signaling pathways. It inhibits nuclear factor kappa B (NF-κB), a transcription factor that plays a crucial role in inflammatory responses. Curcumin also affects the activity of various enzymes and receptors, including cyclooxygenase-2 (COX-2) and lipoxygenase, which are involved in inflammation. Additionally, curcumin has been shown to influence the expression of various genes related to inflammation and oxidative stress.

Pharmacodynamics

Haldi has demonstrated a range of pharmacological effects, primarily attributed to its anti-inflammatory and antioxidant properties. It can help reduce inflammation by inhibiting pro-inflammatory cytokines and enzymes. Curcumin's antioxidant activity helps neutralize free radicals, reducing oxidative stress and preventing cellular damage. Furthermore, it may have a potential role in modulating metabolic processes, enhancing insulin sensitivity, and supporting cardiovascular health.

Pharmacokinetics

Curcumin has low bioavailability due to its poor absorption in the gastrointestinal tract, rapid metabolism, and systemic elimination. It is primarily metabolized in the liver and intestines, resulting in the formation of various metabolites. The peak plasma concentration of curcumin occurs approximately 1-2 hours after oral administration, but due to its rapid clearance, its effects may be short-lived. Co-administration with substances like black pepper (which contains piperine) has been shown to enhance curcumin absorption significantly.

Contra-indications

• Hypersensitivity to curcumin or any of the excipients
• Biliary obstruction
• Gallbladder disorders

Adverse effects

• Gastrointestinal upset
• Nausea
• Diarrhea
• Allergic skin reactions
• Increased risk of bleeding

Interactions

• Anticoagulants and antiplatelet drugs (may increase bleeding risk)
• Drugs that lower blood sugar (may enhance hypoglycemic effect)
• Proton pump inhibitors (may alter absorption)

Precautions

• Use with caution in patients with gallstones or bile duct obstruction
• Monitor for signs of bleeding in patients on anticoagulant therapy
• Use cautiously in pregnant women and those with liver disease

Pregnancy

Limited data on safety, use only if potential benefits justify the risks.

Breast-feeding

Considered safe in small amounts, but high doses should be avoided.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powdered form
• Capsules
• Liquid extracts
• Tea

Indications

• Anti-inflammatory conditions
• Infections (bacterial and fungal)
• Skin disorders (such as eczema and psoriasis)
• Antioxidant support
• Digestive issues

Dosage

Children: Dosage

Adults: Dosage for karanj is not standardized and should be determined based on the specific formulation and indication. It is advisable to consult with a healthcare professional or refer to established guidelines.

Mechanism of action

The bioactive compounds in karanj exhibit various mechanisms of action, including inhibition of pro-inflammatory cytokines and modulation of immune responses. Specific flavonoids present in the seeds have been shown to exert antioxidant effects by scavenging free radicals and reducing oxidative stress. Additionally, some constituents may have antibacterial and antifungal properties, contributing to its traditional use in treating infections.

Pharmacodynamics

The pharmacodynamic properties of karanj are attributed to its various constituents, which work synergistically. The anti-inflammatory effects are primarily due to the inhibition of inflammatory pathways, while the antioxidant activity helps protect cells from damage. The antimicrobial properties are linked to the ability of certain compounds to disrupt microbial cell membranes and inhibit their growth. As a herbal remedy, the efficacy and safety profiles can vary based on preparation methods and dosages.

Pharmacokinetics

The pharmacokinetics of karanj are not extensively studied, but the absorption, distribution, metabolism, and excretion of its active compounds can be influenced by their chemical nature. Generally, flavonoids and other polyphenolic compounds are known to be absorbed in the gastrointestinal tract, with varying bioavailability. Metabolism typically occurs in the liver, where these compounds may undergo phase I and phase II reactions before excretion through urine or feces. The pharmacokinetic profiles can be affected by factors such as formulation, dosage, and individual patient characteristics.

Pregnancy

There is insufficient reliable data on the safety of karanj during pregnancy. It is advisable to avoid use unless the potential benefits outweigh the risks.

Breast-feeding

Limited data is available on the excretion of karanj in breast milk. Caution is recommended, and breastfeeding mothers should consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Respiratory issues
• Digestive disturbances
• Anti-inflammatory purposes
• Immune support

Dosage

Children: Specific dosing information for paediatric use is not available. It is advisable to refer to relevant herbal medicine guidelines or consult with a healthcare professional.

Adults: Specific dosing information for adults is not available. It is advisable to refer to relevant herbal medicine guidelines or consult with a healthcare professional.

Mechanism of action

The exact mechanism of action of Kunvar is not well defined in scientific literature. However, it is believed that the herbal components may exert anti-inflammatory, antioxidant, and antimicrobial effects, contributing to its therapeutic properties. These activities are thought to involve modulation of various cellular signaling pathways and inhibition of pro-inflammatory cytokines.

Pharmacodynamics

Pharmacodynamics of Kunvar may involve the interaction of its active components with specific receptors or enzymes in the body, leading to physiological changes. Common effects may include reduction in inflammation, enhancement of immune responses, and improvement in digestive health. However, due to variable composition, the pharmacodynamic profile can differ widely between formulations.

Pharmacokinetics

The pharmacokinetics of Kunvar is not well characterized due to a lack of comprehensive studies. Absorption, distribution, metabolism, and excretion can vary significantly based on the herbal formulation and individual patient factors. Generally, herbal remedies may have variable bioavailability and their effects can be influenced by factors such as age, diet, and concurrent medications.

Pregnancy

The safety of Kunvar during pregnancy has not been established. Use only if the potential benefit justifies the risk to the fetus.

Breast-feeding

Caution is advised when using Kunvar during breastfeeding. Consult a healthcare professional before use.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Chronic pain
• Nausea and vomiting associated with chemotherapy
• Spasticity in multiple sclerosis

Mechanism of action

The primary mechanism of action for cannabinoids involves their interaction with the endocannabinoid system (ECS), specifically binding to the cannabinoid receptors CB1 and CB2. CB1 receptors, predominantly located in the central nervous system, mediate the psychoactive effects of THC, while CB2 receptors, primarily found in the peripheral immune system, are associated with anti-inflammatory and analgesic effects. Activation of these receptors modulates neurotransmitter release, thereby influencing pain perception, mood, and other physiological processes.

Pharmacodynamics

Cannabis exerts a range of pharmacological effects, including analgesia, anti-inflammatory actions, muscle relaxation, and appetite stimulation. THC is the principal psychoactive component, producing effects such as euphoria, altered perception, and impaired cognitive function. CBD, on the other hand, is non-psychoactive and is noted for its potential anxiolytic, antipsychotic, and neuroprotective properties. The balance of these cannabinoids can lead to different therapeutic outcomes, depending on the strain and formulation used.

Pharmacokinetics

Cannabinoids are typically administered via inhalation, oral ingestion, or topical application, with each route affecting the pharmacokinetics. After inhalation, THC rapidly enters the bloodstream, with peak plasma concentrations occurring within minutes, while the effects can last for several hours. When ingested orally, onset is delayed, with peak effects occurring 1 to 3 hours post-consumption, influenced by factors such as food intake. Cannabinoids are extensively metabolized in the liver, primarily by cytochrome P450 enzymes, resulting in active metabolites. The elimination half-life can vary significantly, with THC being stored in fatty tissues and released over time, contributing to prolonged effects.

Adverse effects

• Altered mental state
• Anxiety
• Paranoia
• Increased heart rate
• Dry mouth
• Dizziness
• Impaired motor coordination

Interactions

• May enhance the effects of central nervous system depressants
• Possible interactions with medications that affect liver enzymes

Precautions

• Use caution in patients with a history of substance abuse
• Monitor for psychological effects
• Consider potential for impaired driving or operation of machinery

Pregnancy

Cannabis use during pregnancy may be associated with adverse outcomes, including low birth weight and developmental issues.

Breast-feeding

Cannabinoids are excreted in breast milk; therefore, caution is advised.

Storage

Store in a cool, dry place, away from direct light and out of reach of children.

Formulations

• Dried flower
• Oils
• Edibles
• Tinctures
• Concentrates

Indications

• Acne
• Psoriasis
• Eczema
• Diabetes management
• Dental health (gingivitis, plaque)
• Antimicrobial treatment
• Anti-inflammatory conditions
• Fungal infections

Dosage

Children: Dosage for children is not well established. Refer to specific product guidelines and consult a healthcare professional for appropriate dosing.

Adults: Dosage varies based on the form of neem used (e.g., oil, powder, extract). Commonly, neem oil is applied topically, while neem powder may be taken orally. Refer to specific product guidelines for dosing recommendations.

Mechanism of action

Neem exhibits its effects through multiple bioactive compounds, including azadirachtin, nimbidin, and nimbin. These compounds interact with various biological pathways, such as inhibiting the synthesis of prostaglandins, modulating immune responses, and exhibiting cytotoxic effects on cancer cells. Neem's antifungal and antibacterial activities are attributed to its ability to disrupt microbial cell structures.

Pharmacodynamics

The pharmacodynamics of neem involve its interaction with various cellular pathways, leading to anti-inflammatory, antipyretic, and analgesic effects. Neem's bioactive compounds can reduce oxidative stress and modulate immune responses by influencing cytokine production. Additionally, neem has been shown to inhibit the growth of pathogens through mechanisms such as disrupting cell wall integrity and interfering with nucleic acid synthesis.

Pharmacokinetics

The pharmacokinetics of neem are not fully characterized; however, it is known that the bioactive compounds are absorbed through the gastrointestinal tract when ingested. The metabolism of neem components may occur in the liver, and elimination is primarily through urine and feces. The half-life of neem's active compounds varies, depending on the specific substance and mode of administration.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Stomach upset
• Skin rash
• Allergic reactions

Precautions

• Should be used with caution in individuals with kidney disorders
• Use with caution in pregnant and breastfeeding women
• May lower blood sugar levels, caution in diabetic patients

Pregnancy

Use during pregnancy is not recommended due to potential adverse effects on the fetus.

Breast-feeding

Use during breastfeeding is not recommended as safety has not been established.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Neem oil
• Neem leaf extract
• Neem powder
• Neem capsules

Indications

• Pain relief
• Anti-inflammatory therapy
• Management of fever

Dosage

Children: Consult a healthcare professional for specific dosing guidelines based on preparation and condition.

Adults: Consult a healthcare professional for specific dosing guidelines based on preparation and condition.

Mechanism of action

The active compounds in patha may exert their effects through various pathways, including the inhibition of cyclooxygenase enzymes, leading to decreased synthesis of prostaglandins, which are mediators of inflammation and pain. Additionally, some compounds may modulate the release of neurotransmitters, further contributing to analgesic effects.

Pharmacodynamics

Patha's pharmacodynamic profile is characterized by its ability to reduce pain and inflammation. The anti-inflammatory effects are likely mediated by the inhibition of inflammatory cytokines and the modulation of immune responses. The analgesic effects may involve central and peripheral mechanisms, affecting pain perception and transmission.

Pharmacokinetics

The pharmacokinetics of patha are not well-characterized due to variability in its preparation and composition. However, it is generally assumed that the active constituents are absorbed through the gastrointestinal tract, metabolized in the liver, and excreted via the kidneys. The onset of action and duration may vary widely based on the formulation and dosage.

Pregnancy

There is limited data on the safety of patha during pregnancy. It is advisable to consult healthcare professionals before use.

Breast-feeding

Caution is advised when using patha while breastfeeding, as safety in lactating women has not been established.

Storage

Store in a cool, dry place away from direct sunlight and out of reach of children.

Indications

• Respiratory infections
• Sore throat
• Cough
• Gastroesophageal reflux disease (GERD)
• Peptic ulcers
• Adrenal insufficiency

Dosage

Children: Refer to established paediatric dosing guidelines or consult

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing based on the specific indication and formulation.

Mechanism of action

Glycyrrhizin inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2, which leads to increased levels of cortisol. This results in enhanced glucocorticoid activity. Additionally, it exhibits anti-inflammatory effects by inhibiting the production of cytokines and other inflammatory mediators. Yashtimadhu also has mucoprotective and expectorant properties, enhancing mucus secretion and facilitating the clearance of respiratory secretions.

Pharmacodynamics

Yashtimadhu exhibits various pharmacodynamic effects, including anti-inflammatory, antiviral, and antioxidant activities. It acts as a demulcent, providing a protective coating to irritated mucous membranes. Its expectorant properties promote productive cough by stimulating mucus secretion and reducing viscosity. The modulation of immune response and reduction of inflammatory cytokines further contribute to its therapeutic effects.

Pharmacokinetics

The pharmacokinetics of Yashtimadhu are influenced by its active constituents. Glycyrrhizin is absorbed in the gastrointestinal tract and metabolized in the liver. It has a half-life of approximately 6 to 8 hours. The bioavailability of glycyrrhizin may be affected by food intake. It is primarily excreted in the urine as both intact compound and metabolites. Long-term use can lead to potential accumulation and side effects, necessitating caution in dosing.

Pregnancy

Yashtimadhu (Glycyrrhiza glabra) is generally considered safe in pregnancy when used in moderation. However, excessive consumption may lead to potential complications such as hypertension and fluid retention. Consultation with a healthcare provider is recommended.

Breast-feeding

Yashtimadhu is typically regarded as safe during breastfeeding, but it is advisable to use it in moderation. There is limited evidence on its effects during lactation, so consulting a healthcare provider is recommended.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Dried root powder
• Extracts (liquid and powdered)
• Teas
• Capsules